What is the diagnosis and treatment for itchy, foul-smelling, dark discolored and raised skin areas below the navel extending to the thigh, lasting 2 months, in a patient with morbid obesity and red eyes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosis and Management of Intertrigo with Secondary Candidal Infection in Morbid Obesity

Most Likely Diagnosis

This clinical presentation is most consistent with intertrigo complicated by secondary candidal infection, given the location (intertriginous areas below navel to thigh), foul odor, dark discoloration, raised appearance, pruritus, and 2-month duration in a morbidly obese patient. 1, 2

The combination of skin fold involvement, moisture retention from obesity, and the characteristic foul smell strongly suggests a mixed bacterial-fungal infection, with candidiasis being the predominant fungal component in intertriginous areas. 1, 3

Key Diagnostic Features

Clinical Characteristics Supporting This Diagnosis

  • Location and patient factors: Obesity is a major predisposing factor for cellulitis and skin infections due to skin fragility, moisture retention, and compromised local defenses. 1
  • Dark discoloration with raised areas: Suggests chronic inflammation with possible lichenification and secondary hyperpigmentation from persistent infection. 1
  • Foul odor: Indicates bacterial superinfection or mixed bacterial-fungal infection, common in intertriginous candidiasis. 1, 3
  • Duration of 2 months: Chronic presentation suggests inadequate treatment or persistent moisture exposure. 2

Red Eyes: Important Consideration

The presence of red eyes warrants consideration of systemic conditions:

  • Reactive arthritis (formerly Reiter's syndrome) can present with conjunctivitis and skin lesions
  • Behçet's disease with mucocutaneous involvement
  • Inflammatory bowel disease with extraintestinal manifestations
  • However, these are less likely given the localized nature and typical intertriginous distribution

Immediate Diagnostic Steps

Confirm Fungal vs. Bacterial Etiology

  • Obtain skin scrapings for potassium hydroxide (KOH) preparation to identify fungal elements (hyphae and budding yeast indicate candidiasis). 3, 4
  • Bacterial culture if purulent exudate, honey-colored crusting, or pustules are present, as these indicate bacterial infection requiring different management. 3
  • Clinical differentiation: Fungal infections show peripheral scaling and satellite lesions without purulent drainage, while bacterial infections present with pustules, purulent exudate, and rapid progression. 3

Treatment Algorithm

Step 1: Address Moisture and Hygiene (Critical First Step)

Keeping the infected area dry is as important as antifungal therapy and is crucial for successful treatment. 2, 5

  • Wash affected areas with gentle cleanser and pat completely dry
  • Apply absorbent powder (not cornstarch, which feeds yeast)
  • Use barrier creams or moisture-wicking fabrics between skin folds
  • Weight loss counseling for long-term management

Step 2: Topical Antifungal Therapy (First-Line)

For candidal intertrigo, topical azoles (clotrimazole or miconazole) or nystatin are equally effective and should be applied twice daily. 2, 5, 3

  • Clotrimazole 1% cream applied twice daily for 2-4 weeks 5, 6, 7
  • Miconazole 2% cream applied twice daily for 2-4 weeks 2, 5
  • Nystatin cream applied 2-4 times daily for 2-4 weeks (alternative if azole intolerance) 5

All three agents have equivalent efficacy for cutaneous candidiasis. 5

Step 3: Address Bacterial Superinfection if Present

If clinical features suggest bacterial involvement (pustules, purulent drainage, honey-colored crusting):

  • Mupirocin 2% ointment applied three times daily for 8-12 days for localized bacterial infection 3, 8
  • Oral antibiotics (cephalexin 500mg four times daily or dicloxacillin 500mg four times daily) if extensive disease or systemic symptoms present 1, 3

Step 4: Consider Systemic Antifungal Therapy

Systemic therapy is indicated if topical treatment fails after 2-4 weeks, infection is extensive (covering large body surface area), or patient compliance with topical therapy is poor. 2, 4, 9

  • Fluconazole 150mg once weekly for 2-4 weeks is effective for extensive tinea corporis/cruris and can be considered for refractory candidal infections 10
  • Oral therapy achieves better penetration in obese patients with deep skin folds 4, 9

Step 5: Anti-inflammatory Therapy (Use With Caution)

If significant inflammation is present:

  • Short-term combination antifungal/steroid cream (e.g., clotrimazole/betamethasone) may provide faster symptom relief 6, 7
  • Caution: Use for maximum 1-2 weeks only due to risk of skin atrophy, especially in intertriginous areas 6
  • The quality of evidence for combination therapy is very low, and it is not recommended in clinical guidelines for routine use 7

Critical Pitfalls to Avoid

Common Treatment Errors

  • Using topical therapy alone for nail involvement: If nails are affected, oral therapy is required as topical agents are ineffective 2
  • Inadequate drying of skin folds: This is the most common reason for treatment failure 2, 5
  • Stopping treatment too early: Continue for at least one week after clinical clearing 6
  • Using combination steroid/antifungal creams long-term: Risk of skin atrophy and steroid-related complications 6

When to Escalate Care

  • Immediate dermatology referral if skin sloughing >30% body surface area (concern for Stevens-Johnson syndrome/toxic epidermal necrolysis) 3
  • Ophthalmology evaluation for the red eyes to rule out uveitis or other serious ocular pathology
  • Rheumatology consultation if systemic symptoms suggest reactive arthritis or other inflammatory conditions
  • Infectious disease consultation if recurrent infections suggest underlying immunosuppression or diabetes 3

Expected Treatment Timeline

  • Clinical improvement: Should be evident within 1-2 weeks of appropriate therapy 6, 7
  • Complete resolution: Typically 2-4 weeks for tinea corporis/cruris; candidal infections may resolve faster with proper moisture control 2, 6
  • Follow-up: Reassess at 2 weeks; if no improvement, consider culture, systemic therapy, or alternative diagnosis 4, 9

Long-Term Prevention

  • Maintain skin fold hygiene and dryness 2
  • Address underlying obesity through weight management 1
  • Treat any tinea pedis or toe web maceration, as these serve as reservoirs for reinfection 1
  • Consider prophylactic antifungal powder in high-risk periods (summer, increased activity) 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment for Skin Fungal Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Bacterial and Fungal Rash Differentiation and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Fungal Infection Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Topical treatment of common superficial tinea infections.

American family physician, 2002

Research

Topical antifungal treatments for tinea cruris and tinea corporis.

The Cochrane database of systematic reviews, 2014

Research

Fungal skin disorders.

Primary care, 2000

Research

Fluconazole in the treatment of tinea corporis and tinea cruris.

Dermatology (Basel, Switzerland), 1998

Related Questions

What is the likely cause and treatment for a persistent low-grade odor in the groin area, possibly related to bacterial overgrowth (e.g., Corynebacterium) or biome disruption, after a previous case of Tinea Cruris (jock itch) and candida overgrowth?
What are the recommended first‑line treatment guidelines for an elderly patient with a localized groin fungal infection (tinea cruris or intertriginous candidiasis) who is afebrile?
What is the likely cause and treatment for a persistent low-grade odor in the groin area, possibly related to chronic bacterial overgrowth (e.g., Corynebacterium) or biome disruption, after a previous case of Tinea Cruris (jock itch) and candida overgrowth?
What is the likely cause and treatment for a persistent low-grade odor in the groin area, possibly related to chronic bacterial overgrowth (e.g., Corynebacterium) or biome disruption, after a previous case of Tinea Cruris (jock itch) and candida overgrowth?
What is the best treatment for jock itch (tinea cruris)?
What is the management of epistaxis?
What is the role of dapagliflozin (SGLT2 inhibitor) in the treatment of heart failure with preserved ejection fraction (HFpEF) based on the DELIVER trial?
What are the recommended wine consumption guidelines for women going through menopause (perimenopause or postmenopause)?
What is the management of atypical pneumonias?
What is the management for a child exposed to cat litter?
What is the appropriate dose of Procrit (epoetin alfa) for a peritoneal dialysis patient weighing 45 kg with severe anemia (Hgb 7.7 g/dL) who is not responding to 20,000 units a week?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.